FutureGen Industries

FutureGen Industries reported a loss per share of CAD 0.06 for the quarter ended March 31, 2026. In the same quarter a year earlier the company had posted a profit of CAD 0.03 per share. No information on revenue or causes was disclosed. » More on finanzen.net

FutureGen Industries reported earnings per share of CAD 0.02 for the quarter ended December 31, 2025. In the year-ago quarter, earnings per share were -CAD 0.010. » More on finanzen.net

FutureGen Industries reports significant realized gains in 2025 from sales of stakes in Onco-Innovations, ASEP Medical Holdings and Core One Labs. The disposals generated proceeds of several hundred thousand US dollars, with Onco-Innovations notably delivering a 9,816% return; ASEP and Core One also produced double- to four-digit returns. The company emphasizes its disciplined investment approach and focus on early-stage stakes in biotech, AI, robotics, quantum and defense to create sustainable shareholder value. » More on finanzen.net